Nuvasive, Inc. v. Absolute Medical, LLC

71 F.4th 861
CourtCourt of Appeals for the Eleventh Circuit
DecidedJune 21, 2023
Docket22-10214
StatusPublished
Cited by5 cases

This text of 71 F.4th 861 (Nuvasive, Inc. v. Absolute Medical, LLC) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nuvasive, Inc. v. Absolute Medical, LLC, 71 F.4th 861 (11th Cir. 2023).

Opinion

USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 1 of 36

[PUBLISH] In the United States Court of Appeals For the Eleventh Circuit

____________________

No. 22-10214 ____________________

NUVASIVE, INC., Plaintiff-Counter Defendant-Appellee, versus ABSOLUTE MEDICAL, LLC, GREG SOUFLERIS, DAVE HAWLEY, ABSOLUTE MEDICAL SYSTEMS, LLC, RYAN MILLER,

Defendants-Appellants,

____________________ USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 2 of 36

2 Opinion of the Court 22-10214

Appeal from the United States District Court for the Middle District of Florida D.C. Docket No. 6:17-cv-02206-CEM-GJK ____________________

Before WILSON and JILL PRYOR, Circuit Judges, and RUIZ,* District Judge. JILL PRYOR, Circuit Judge: NuVasive, Inc. manufactures medical products and equip- ment to treat spinal disease. In central Florida, NuVasive sold its products through an exclusive distribution agreement with Abso- lute Medical, LLC, a company owned by Greg Soufleris. Under the agreement, Absolute Medical employed independent-contractor sales representatives who marketed and sold NuVasive’s products to doctors and medical practices in the region. Long before the end of the agreement’s term, Soufleris informed NuVasive that he was dissolving Absolute Medical and ending its business relationship with NuVasive. He started a new company, Absolute Medical Sys- tems, LLC (“AMS”), which began selling products for one of NuVa- sive’s competitors. NuVasive sued Absolute Medical, Soufleris, AMS, and two of Absolute Medical’s sales representatives who began working for AMS, Dave Hawley and Ryan Miller, for breaching the exclusive

* Honorable Rodolfo A. Ruiz II, United States District Judge for the Southern District of Florida, sitting by designation. USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 3 of 36

22-10214 Opinion of the Court 3

distribution agreement and the included noncompetition agree- ments. After two years of litigation, the district court enforced a dispute resolution clause in the agreement, ordering NuVasive and Absolute Medical to arbitrate NuVasive’s breach-of-contract claim seeking money damages. The district court stayed most of the other claims during the arbitration. The arbitration panel’s final award found Absolute Medical liable for breaching the agreement but denied NuVasive’s claims for lost profits damages. Following arbitration, the litigation resumed to resolve NuVasive’s remaining claims.1 In discovery, Absolute Medical pro- duced text messages that Soufleris had sent to Hawley while Haw- ley testified before the arbitration panel. The text messages con- cerned the subject matter of Hawley’s testimony, and his testi- mony on cross-examination appeared to be consistent with an- swers suggested in Soufleris’s contemporaneous texts. Based on this new information, NuVasive moved the district court to vacate the arbitration panel’s award under 9 U.S.C. § 10(a)(1) on the ground that the award had been procured by fraud. Absolute Med- ical objected that NuVasive filed the motion to vacate after the

1 While the arbitration was pending, NuVasive moved for summary judgment on its breach-of-contract claim against Absolute Medical that sought injunc- tive relief (Count I), the breach-of-contract claim against AMS (Count III), and the breach-of-contract claim against Hawley and Miller (Count IV). Hawley, Miller, and AMS moved for summary judgment on the breach-of-contract claim against Hawley and Miller and the conversion claim against Hawley and AMS (Count V). USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 4 of 36

4 Opinion of the Court 22-10214

statutory three-month deadline, but the district court tolled the deadline and ultimately vacated the arbitration panel’s award. Absolute Medical, Soufleris, AMS, and the sales representa- tives now appeal the district court’s order granting NuVasive’s mo- tion to vacate the arbitration panel’s final award. After careful re- view, and with the benefit of oral argument, we affirm. I. BACKGROUND A. NuVasive and Absolute Medical’s Business Relation- ship NuVasive is a medical device manufacturer that designs, de- velops, and markets products for the surgical treatment of spinal disorders. Absolute Medical, owned by Soufleris, employed inde- pendent contractors to act as sales representatives to market and sell NuVasive’s products to hospitals and doctors. Around 2005, Absolute Medical began working with NuVa- sive to market and sell NuVasive’s products in central Florida. By 2013, NuVasive and Absolute Medical had entered into an exclu- sive distribution arrangement in which Absolute Medical and its sales representatives would be the sole marketers, distributors, and sellers of NuVasive’s products in a defined territory in Florida that included specific counties as well as certain hospitals in other coun- ties. This appeal concerns the contract NuVasive and Absolute Medical inked in 2017, when they agreed to extend their exclusive distribution relationship “after many months of negotiation[].” USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 5 of 36

22-10214 Opinion of the Court 5

Doc. 1 at 4. 2 This contract, entitled “Exclusive Sales Representative Agreement” (the “Agreement”), had a term of five years beginning on January 1, 2017. Like the earlier agreement, it appointed Abso- lute Medical and its sales representatives as the exclusive sellers of NuVasive’s products in the defined territory. In section 5.09(c) of the Agreement, Absolute Medical promised that during the Agree- ment’s five-year term and for one year afterward, Absolute Medi- cal’s sales representatives would not “represent, promote, sell, so- licit, or otherwise commercialize . . . any products or services that [we]re, in NuVasive’s reasonable judgment, competitive with any of NuVasive’s products or services.” Doc. 260-3 at 137. Absolute Medical further agreed that, during the same period, its sales rep- resentatives would not “solicit, encourage, or induce, or cause to be solicited, encouraged or induced” any current, former, or pro- spective NuVasive customers “to terminate or adversely modify any business relationship with NuVasive.” Id. In exchange, NuVa- sive agreed to provide Absolute Medical’s sales representatives with “extraordinary, specialized, comprehensive, and industry- leading training” on NuVasive’s products, which would give the sales representatives “a deep understanding of NuVasive’s prod- ucts, methodology, trade secrets, and other valuable confidential or proprietary information.” Doc. 188 ¶ 30. To effect section 5.09(c)’s non-competition and non-solicita- tion provisions, section 5.09(e) of the Agreement required Absolute

2 “Doc.” refers to the docket entries in No. 6:17-cv-02206 (M.D. Fla.). USCA11 Case: 22-10214 Document: 43-1 Date Filed: 06/21/2023 Page: 6 of 36

6 Opinion of the Court 22-10214

Medical to cause each of its “Representative Affiliate[s]”—in Abso- lute Medical’s case, its sales representatives—to sign compliance agreements. The compliance agreements incorporated section 5.09(c) of the Agreement. To comply with section 5.09(e), Absolute Medical agreed to have its sales representatives, including Hawley and Miller, sign compliance agreements. Less than one year into the Agreement’s five-year term, Sou- fleris informed NuVasive by email of his “resignation” from the Agreement because “[his] time [had] come to move on.” Doc. 188- 4. Just three days later, Soufleris formed AMS. After a week, the Absolute Medical sales representatives who sold NuVasive prod- ucts resigned.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
71 F.4th 861, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nuvasive-inc-v-absolute-medical-llc-ca11-2023.